A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma.
Piper E, Brightling C, Niven R, Oh C, Faggioni R, Poon K, She D, Kell C, May RD, Geba GP, Molfino NA.
Piper E, et al.
Eur Respir J. 2013 Feb;41(2):330-8. doi: 10.1183/09031936.00223411. Epub 2012 Jun 27.
Eur Respir J. 2013.
PMID: 22743678
Free PMC article.
Clinical Trial.